Careviso SeeQer
Insurance Eligibility & Benefits Verification
About
Careviso provides the seeQer platform, a healthcare transparency software designed for healthcare administrators and providers. It streamlines processes such as prior authorizations, benefits investigation, and patient eligibility verification, while also providing clear insights into patients' financial responsibilities for their treatment. The platform aims to reduce administrative burdens, save time, and empower patients with informed decision-making regarding their care. Teams look it up for Insurance Eligibility & Benefits Verification, HealthTech, InsurTech.
Frequently asked
What does Careviso SeeQer do?
Careviso SeeQer is an Insurance Eligibility & Benefits Verification company that offers Software. Teams look it up for HealthTech, InsurTech, Revenue Cycle Management. It is based in Vienna, United States and was founded in 2017. Public records show about 79 people and $17M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Careviso SeeQer raised?
Careviso SeeQer has raised a total of $17M in funding. The most recent round on record is Series B.
Where is Careviso SeeQer headquartered?
Careviso SeeQer is headquartered in Vienna, United States.
When was Careviso SeeQer founded?
Careviso SeeQer was founded in 2017.
What industry does Careviso SeeQer operate in?
Careviso SeeQer operates in Insurance Eligibility & Benefits Verification, HealthTech, InsurTech, Revenue Cycle Management, Patient Access.
How many employees does Careviso SeeQer have?
Careviso SeeQer has approximately 79 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.